HFB3024

N/A

Report date: 2025/04/28 17:05:08
NME

Base Information

Drug NameHFB3024
Drug Alias NameHFB3024HFB-3024
ClassificationOther
Mechanisms of ActionKiller cell lectin-like receptor subfamily G member 1 modulators
TargetsKiller cell lectin-like receptor subfamily G member 1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHiFiBiO Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A